Nifurtoinol

{{drugbox | IUPAC_name = 3-(hydroxymethyl)-1-{[(1E)-(5-nitro-2-furyl)
methylene]amino}imidazolidine-2,4-dione | image = Nifurtoinol.png | CAS_number = 1088-92-2 | ATC_prefix = J01 | ATC_suffix = XE02 | PubChem = 9571062 | DrugBank = | C=9|H=8|N=4|O=6 | molecular_weight = 268.183 g/mol | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = Renal (40–50% within the first 12 hours) | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = Oral }}

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]